Singapore-US Strategic Dialogue on Biosecurity
Date
2014-07Metadata
Show full item recordAbstract
Singapore is poised to be a critical partner to the US in minimizing biosecurity challenges in Southeast
Asia. As a nation, it is vulnerable to both emerging infectious disease and potential terrorism in the
region. In addition to its geographical importance within the Asia-Pacific region, Singapore is a rising
powerhouse in biotechnology, having invested $13.2B in biotech R&D from 2011-2015. As a result, it has
become an attractive site for international biotechnology companies like Novartis, as well as world-class
research universities. It is home to government and academic expertise capable of identifying and
responding to biosecurity challenges. Its expertise is, in many ways, complementary to that of the US in
these realms.